Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Kathleen N. Moore, MD, University of Oklahoma
home
Articles
Future of Advanced Endometrial Cancer
January 4th 2021
Novel Targets for Advanced Endometrial Cancer
January 4th 2021
Endometrial Cancer: Chemo-Free Regimens on the Horizon
January 4th 2021
Emerging Agents: Treatment of Endometrial Cancer
January 4th 2021
Sequencing for Advanced Endometrial Cancer
January 4th 2021
Recurrent Endometrial Cancer: Safety of Combination Therapy
January 4th 2021
Combination Therapy for Recurrent Endometrial Cancer
January 4th 2021
Emerging ICI Therapy for Advanced Endometrial Cancer
January 4th 2021
Immune Checkpoint Inhibitors in Advanced Endometrial Cancer
January 4th 2021
GOG-258 and PORTEC-3 Studies in Endometrial Cancer
January 4th 2021
GOG-249 Study in Early-Stage Endometrial Cancer
January 4th 2021
GOG 0209 Study in Advanced Endometrial Cancer
January 4th 2021
Role of Biomarker Testing in Endometrial Cancer
January 4th 2021
Risk Classification of Endometrial Cancer
January 4th 2021
Overview of Endometrial Cancer
January 4th 2021
Systemic Management of Ovarian Cancer: Closing Thoughts
May 27th 2020
Novel Combination Strategies in Recurrent Ovarian Cancer
May 27th 2020
Recurrent Ovarian Cancer: Novel Agents Under Investigation
May 27th 2020
Bevacizumab’s Role in Recurrent Ovarian Cancer
May 27th 2020
Recurrent Ovarian Cancer: Choosing a PARP Inhibitor
May 27th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE